ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 302035 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 302035; 2) Community: the network communities that were significantly associated with the response to NSC 302035; 3) Molecule: the relationships between components within communities and NSC 302035; 4) MDR: the compounds that were significantly associated with the NSC 302035.

NSC Compound Enrichment Correlation
NSC 114346 Null 0.00626555836518792 0.49484624
NSC 135880 Null 0.00626555836518792 0.38500122
NSC 354974 Acetamide, N-(5,6,7,9-tetrahydro-2,3-dihydroxy-1,10-dimethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)- 0.00626555836518794 0.2981552
NSC 372155 2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- 0.00626555836518794 0.722054
NSC 39215 Null 0.00626555836518794 0.55087839
NSC 633963 N,N'-Di{1-methyl-2-[1-methyl-2-carboxamido(3-propionamidine) -4-pyrrole]-4-pyrrolyl}suberamide dihydrochloride 0.00626555836518794 -0.0010230375
NSC 649904 Cyclopentanone, 5-[(4-morpholinyl)methyl]-2-pentylidene-, hydrochloride 0.00626555836518794 0.67843233
NSC 651605 Null 0.00626555836518794 0.21578258
NSC 679006 2-Butenedioic acid, 2,2'-(5-methyl-2,4-dioxopyrimidine- 1,3-diyl)bis-, tetraethyl ester 0.00626555836518794 0.80909409
NSC 683694 Null 0.00626555836518794 0.33522106
Total:95  Current:21    [First] [Prev] [Next] [Last]